Healthcare
Monday, December 5, 2016
BRIEF-Biotest says encouraging data of indatuximab ravtansine in combination therapy in advanced multiple myeloma
* Encouraging data of Indatuximab Ravtansine (BT-062) in
combination therapy in advanced multiple myeloma
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment